Visit the Web Pages Hosted by HR-Net Read the Convention Relating to the Regime of the Straits (24 July 1923) Read the Convention Relating to the Regime of the Straits (24 July 1923)
HR-Net - Hellenic Resources Network Compact version
Today's Suggestion
Read The "Macedonian Question" (by Maria Nystazopoulou-Pelekidou)
HomeAbout HR-NetNewsWeb SitesDocumentsOnline HelpUsage InformationContact us
Thursday, 28 March 2024
 
News
  Latest News (All)
     From Greece
     From Cyprus
     From Europe
     From Balkans
     From Turkey
     From USA
  Announcements
  World Press
  News Archives
Web Sites
  Hosted
  Mirrored
  Interesting Nodes
Documents
  Special Topics
  Treaties, Conventions
  Constitutions
  U.S. Agencies
  Cyprus Problem
  Other
Services
  Personal NewsPaper
  Greek Fonts
  Tools
  F.A.Q.
 

Athens Macedonian News Agency: News in English, 16-10-11

Athens News Agency: News in English Directory - Previous Article - Next Article

From: The Athens News Agency at <http://www.ana.gr/>

CONTENTS

  • [01] Finance ministry: Remaining 1.7 bln euros of loan to be disbursed by ESM on Oct. 24
  • [02] New drug called luspatercept could help end transfusions for thalassemia patients

  • [01] Finance ministry: Remaining 1.7 bln euros of loan to be disbursed by ESM on Oct. 24

    The European Stability Mechanism (ESM) will announce at its next meeting on October 24 the disbursement of the 1.7-billion-euro sub-tranche, when the September data for the state's repayments of arrears to the private sector will be available, the finance ministry said in a press release on Monday.

    According to the ministry, the data will show the target has been exceeded. The Eurogroup on Monday approved the immediate disbursement of the 1.1 billion euros to Greece that will service the country's debt, recognizing that all the milestones of the first program review have been implemented.

    [02] New drug called luspatercept could help end transfusions for thalassemia patients

    The new drug luspatercept, now under development in the United States, could help to significantly reduce or even eliminate the need for transfusions for thalassemia patients, the medical consultant of the Thalassemia International Federation Michalis Angastiniotis told the Athens-Macedonian News Agency (ANA) on Monday.

    Speaking on the sidelines of a Balkans Thalassemia Conference taking place in Thessaloniki, Angastiniotis said that clinical trials were now in their third phase and are expected to be completed in roughly 18 months.

    He said that luspatercept acts on the red blood cells during their formation, increasing the number of healthy red blood cells in the circulatory system. In mild cases of thalassemia, where a patient was not fully dependent on transfusions, it could eliminate the need for them entirely. In more severe cases, where a patient was fully dependent, the number of tranfusions necessary are reduced by 40 pct on average but this can rise to as much as 80 pct for some individuals.

    Fewer transfusions would mean fewer complications, thus also reducing the necessity for the close monitoring that thalassemia patients normally need and greatly improve their quality of life, he added.

    Angastiniotis noted that gene therapy was also entering the third phase of clinical trials at this time, with 25 patients having undergone treatment throughout the world. The first patient that started the treatment seven years ago did not need transfusions but also suffered some negative side-effects, which Angastiniotis said was "not strange, given that it is the first time a treatment of this kind was administered."

    More recent cases had given "relatively good results," he said and there were signs of further improvements in the future.

    Thessaloniki will be among the first cities in the world where trials for both luspatercept and gene therapy for thalassemia will take place, at the Papanicolaou Hospital's Gene and Cell Therapy Centre, which is among the most advanced in Europe.


    Athens News Agency: News in English Directory - Previous Article - Next Article
    Back to Top
    Copyright © 1995-2023 HR-Net (Hellenic Resources Network). An HRI Project.
    All Rights Reserved.

    HTML by the HR-Net Group / Hellenic Resources Institute, Inc.
    ana2html v2.01 run on Tuesday, 11 October 2016 - 8:38:09 UTC